期刊名称：DISEASES OF THE COLON & RECTUM
 期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
When it comes to professional presence, Diseases of the Colon & Rectum (DC&R) is an acknowledged leader. Over four decades of experience and two prestigious societies back this reputable publication to make it the journal of choice among colorectal surgeons worldwide. Today it is constantly evolving to meet the needs of patients and practitioners in this fast-changing specialty. Gastroenterologists and general surgeons also have discovered that DC&R is the place to be for the latest in medical and surgical concepts.
Diseases of the Colon & Rectum is the journal of choice for colorectal surgeons, providing an excellent resource for gastroenterologists, and general surgeons who want the latest in medical surgical concepts.
Official Journal of
¡¤ American Society of Colon and Rectal Surgeons
¡¤ International Society of University Colon and Rectal Surgeons
¡¤ Colorectal Surgical Society of Australasia
Instructions to Authors
Copyright Transfer Statement:
A copyright transfer statement signed by all the authors must be included with the manuscript submission. Submissions received without a signed copyright statement cannot be sent out for review. The copyright transfer form is available for download at: https://www.editorialmanager.com/dcr/. After signing, scan and upload as a separate file with the manuscript into Editorial Manager.
Disclosure Statement:
The senior author must certify in writing that the authors of the article either have or do not have commercial associations (e.g., consultancies, stock ownership, equity interests, patent-licensing arrangements, research support, speaker’s bureau, etc.) that might pose a conflict of interest in connection with the submitted article. The disclosure statement should be submitted in letter form. After signing, scan and upload as a separate file with the manuscript into Editorial Manager.
MANUSCRIPT SUBMISSION GUIDELINES
All manuscripts must be submitted on-line through the web site at https://www.editorialmanager.com/dcr/.
First-time users: Please click the Register button from the menu above and enter the requested information. On successful registration, you will be sent an e-mail indicating your user name and password. Once you have an assigned ID and password, you do not have to re-register, even if your status changes (that is, author, reviewer, or editor). NOTE: If you have received an e-mail from us with an assigned user ID and password, or if you are a repeat user, do not register again. Just log in.
Authors: Please click the log-in button from the menu at the top of the page and log in to the system as an Author. Submit your manuscript according to the author instructions. You will be able to track the progress of your manuscript through the system. If you experience any problems, please contact seabright.irene@mayo.edu.
SYSTEM REQUIREMENTS
System requirements can be found at http://www.editorialmanager.com/homepage/faq.html#faq11
ARTICLE TYPES
ORIGINAL CONTRIBUTIONS:
This category includes original research including both clinical and basic science submissions. The work must be original and neither published, accepted, or submitted for publication elsewhere. Any related work, either SUBMITTED, in press, or published from any of the authors should be clearly cited and referenced.
All clinical trials must be registered in a public trials registry that is acceptable to the International Committee of Medical Journals Editors (ICMJE). Go to (http://www.icmje.org/faq.html). Authors of randomized controlled trials must adhere to the CONSORT guidelines, available at: www.consort-statement.org, and provide both a CONSORT checklist and flow diagram.
All authors are expected to abide by accepted ethical standards for human and animal investigation. In studies that involve human subjects or laboratory animals, authors must provide an explicit statement in Materials and Methods that the experimental protocol was approved by the appropriate institutional review committee and meets the guidelines of their responsible governmental agency. In the case of human subjects, informed consent, in addition to institutional review board approval, is required.
Only a limited number of BASIC SCIENCE PAPERS are considered for publication. These are selected at the discretion of the editor(s) based upon novelty, relevance, and the quality of the research.
TECHNICAL NOTES:
Technical notes should be a brief communication describing a novel surgical technique. Individual case vignettes should not be included in the manuscript. Technical notes should not be more than 1500 words.
CASE REPORTS:
Case reports are no longer being considered for publication.
COLLECTED REVIEWS:
Submissions should address a topic of current interest. Meta-analysis and systematic reviews of randomized controlled trials must adhere to the guidelines outlined in the PRISMA statement. For the most up-to-date information about these guidelines and access to future revisions, visit http://www.prisma-statement.org.
On occasion the Editors will solicit a clinical review addressing a specific topic of current interest.
All review articles are subject to the usual peer review process. Advice regarding suitability of a topic is available from the Editorial Office.
FOR DEBATE:
The purpose of this section is to provide a forum for novel ideas, theories, or concepts with the goal of promoting discussion and research. Articles are selected based upon novelty, relevance, persuasiveness and clarity of expression. Manuscripts should be no longer than 2500 words/20 references.
DYNAMIC ARTICLE:
Stand-alone video submissions are NOT allowed. Dynamic articles (which are COMPLETE MANUSCRIPTS with video(s) included strictly as supplemental electronic material) are the ONLY type of video submissions considered. Standard instructions for manuscript submission should be followed. The manuscript, with supplemental video(s), should include title page, structured abstract and classifications, manuscript text, and references. Up to 3 videos (included only as supplemental materials) and each up to one-minute in length maximum per manuscript submission will be considered. Be sure to note in your manuscript the placement of the video clip(s). Videos MUST be narrated and in English. The content of the files must be identical to that reviewed and accepted by the editors of Diseases of the Colon & Rectum. For submission instructions of videos, go to http://links.lww.com/a142. NOTE: for videos larger than 10 MB, only .wmv, .swf, and .flv formats are accepted.
LETTER TO EDITOR:
Letters to the Editor are only accepted on a very limited basis. Submissions should be no longer than 250 words.
MANUSCRIPT PREPARATION GUIDELINES
GENERAL INSTRUCTIONS:
Manuscripts are to be double-spaced with a 12-pt. font and written in colloquial, professional English. Authors are urged to aim for clarity, brevity, and accuracy of information and language. Authors whose first language is not English should have their papers checked for linguistic accuracy by a professional editor who is a native English speaker. Each manuscript page should be numbered.
Manuscripts are limited to no more than 3000 words (main text only, does not include abstract, references, tables, legends, and figures). References are limited to no more than 40, with the exception of review articles, systematic reviews, and meta-analyses.
The maximum number of authors on a manuscript is usually 8, but occasional exceptions are made. Requests for exception must be directed to the Editorial Office PRIOR to manuscript submission. Please follow the International Committee of Medical Journal Editors (ICMJE) recommendations for authorship criteria (http://www.icmje.org/#author). For those contributors who do not fulfill authorship criteria, we are happy to acknowledge them in a list at the end of the paper.
MANUSCRIPT FORMAT AND SEQUENCE
TITLE PAGE:
Title page should contain: 1. The title of the article; 2. A short running head of no more than 40 characters (count letters and spaces); 3. First name, middle initial, last name, highest academic degree, and institution/department for each author; 4. Name, address, telephone, fax, and current e-mail address of author responsible for correspondence about the manuscript; 5. Disclaimers; 6. Source(s) of support in the form of grants, equipment, drugs, or all of these, or state if there is no funding; authors should explicitly list any relevant financial relationships (see Disclosure Statement) or state explicitly that there are none; 7. State if manuscript has been or will be a podium or poster meeting presentation and provide the name of the meeting, location (city, state and country if not U.S.), and include start AND end dates of the ENTIRE meeting; 8. State the word count for the text; 9. State the word count for the abstract; 10. List the contribution of each author/coauthor. Authorship credit should be based on a. Substantial contributions to conception and design, or acquisition of data, or analysis and interpretation of data; b. Drafting the article or revising it critically for important intellectual content; c. Final approval of the version to be published. Authors should meet all three of these conditions. Please note that while many activities (for example, supplying patients, maintaining a database, obtaining follow-up data, and providing criticism of a manuscript) are unquestionably important, none of these activities alone suffices for authorship. We are happy to acknowledge contributors who do not fulfill authorship criteria at the end of the paper. Our policy is based upon the "Uniform Requirements for Manuscripts Submitted to Biomedical Journals" statement of the International Committee of Medical Journal Editors (http://www.icmje.org/#author).
Trade names, as well as Trademark and Registered symbols, are not allowed in the title. When relevant, trade names may be used once in the body of the article preceded by a generic description (e.g., a drug or device name); the generic name should be used subsequently throughout the article.
STRUCTURED ABSTRACT:
The structured abstract should not be more than 300 words in the order of Purpose, Methods, Results, and Conclusions. No abbreviations are allowed in the abstract. Do not provide any manufacturer information in the abstract. Organize structured abstracts for the articles shown below:
Original Contribution: Background, Objective, Design, Settings, Patients, Intervention(s) if any, Main Outcome Measures, Results, Limitations, Conclusions.
Systematic Reviews, including Meta-analyses: Background, Objective, Data Sources, Study Selection, Intervention(s), Main Outcome Measures, Results, Limitations, Conclusions.
(Cummings P, Rivara FR, Koepsell TD. Writing informative abstracts for journal articles. Arch Pediatr Adolesc Med. 2004;158:1086-1088.)
CLASSIFICATIONS:
Select up to 6 classifications from the list provided in Editorial Manager that will assist in cross-indexing your article and that may be published with the structured abstract.
TEXT:
Arrange in the following order:
1. Introduction: Clearly state the purpose of the article. Summarize the rationale for the study or observation. Give only strictly pertinent references, and do not review the subject extensively;
2. Materials and Methods: Describe your selection of the observational or experimental subjects clearly (patients or experimental animals, including controls). Provide an explicit statement that the experimental protocols were approved by the appropriate institutional review committee and meet the guidelines of the responsible governmental agency. In the case of human subjects, state explicitly those subjects have provided informed consent. Identify the methods, apparatus/product** (with manufacturer’s name and address in parentheses), and procedures in sufficient detail to allow other workers to reproduce the results. Give references to established methods, including statistical methods; provide references and brief descriptions of methods that have been published but are not well known, describe substantially modified methods, including statistical methods, give reasons for using them, and evaluate their limitations;
3. Results: Present your results in a logical sequence in the text, tables, and figures. Do not repeat in the text all the data in the tables and/or illustrations; emphasize or summarize only important observations;
4. Discussion: The discussion should be formatted as follows:
* Concise statement of principal findings;
* Strengths and weaknesses of the study;
* Strengths and weaknesses of the study in relation to other studies, discussing particularly any differences in results;
* Meaning of the study: possible mechanisms and implications for clinicians or policymakers;
* Unanswered questions and future research.
(Docherty M, Smith R. The case for structuring the discussion of scientific papers. BMJ. 1999;318:1224-1225.)
Please avoid restating the results of the study and avoid lengthy literature reviews.
**Product Information:
For apparatus/product(s), supply exact product name(s) and supply the manufacturer's name(s) and location(s) (including city, state, and country) for all products mentioned throughout the text. (NOTE: If no specific product name is mentioned, supplying the manufacturer information is optional.)
Acknowledgments:
Only acknowledge persons who have made substantive contributions to the study. Authors are responsible for obtaining written permission from everyone acknowledged by name because readers may infer their endorsement of the data and conclusions. Begin your text of the acknowledgment with, “The authors thank…”.
References:
The author is responsible for the accuracy of the references. Citations in the text should be identified by superscript Arabic numerals without parentheses, and the list of the references at the end of the paper should be numbered consecutively in the order they are first mentioned in the text. Authors should identify references in the text, tables, and legends. Only works referred to in the text and already accepted for publication can be included. For seven or more authors please list the first three authors followed by et al. Please use a maximum of 40 references for each manuscript submitted, with the exception of review articles and meta-analyses. Click here for limited examples. For very detailed instructions on citing references, refer to the AMA Manual of Style, 10th Edition beginning on page 39.
Tables:
Each table should be numbered consecutively with Arabic numerals. Footnotes to tables should be indicated by lowercase superscript letters.
Legends:
Legends must be brief, self-sufficient explanations of the figures and tables in no more than four or five lines. Remarks such as “For explanation, see text” should be avoided. The legends should be typed double-spaced on a separate page. When symbols, arrows, numbers or letters are used to identify parts of the illustration, identify and explain each one clearly.
FIGURES:
Figures should be limited to those essential for the text. The same results should be presented as either the graph or tables, not as both. Click here for additional detailed instructions.
NOTE: After following the instructions in the above link, and after all figures have been uploaded into Editorial Manager, you must click on the Artwork link in Editorial Mananger to determine if each figure shows a designation of Pass. If a figure shows Fail, send an e-mail to seabright.irene@mayo.edu for additional assistance.
REVISED MANUSCRIPTS:
Diseases of the Colon & Rectum reserves the right to request a statistical or other additional expert review of a paper at any time during the review process and not just during the initial review. A request for revisions does not guarantee acceptance of the revised manuscript.
CONSENSUS STATEMENTS
Diseases of the Colon & Rectum is a co-sponsor of the Surgical Journal Editors Group. Authors must be in compliance on authorship criteria and trial registration: Consensus statement on submission and publication of manuscripts. Dis Colon Rectum. 2001;44:767-768; Consensus statement on surgery journal authorship. Dis Colon Rectum. 2006;49:789-790.
LEGAL REQUIREMENTS
Submission of a manuscript implies: that the work described has not been published before; that it is not under consideration for publication anywhere else; that its publication has been approved by all coauthors, if any, as well as by the responsible authorities—tacitly or explicitly—at the institute where the work has been carried out. Neither the Publisher nor Society will be held legally responsible should there be any claims for compensation.
PERMISSIONS:
Authors wishing to include figures, tables, or text passages that have already been published elsewhere are required to obtain permission from the copyright owner(s) and to include evidence that such permission has been granted when submitting their papers. Any material received without such evidence will be assumed to originate from the authors.
CROSSCHECK:
Diseases of the Colon & Rectum utilizes the online tool CrossCheck to randomly check submitted materials against published scholarly research papers and the open web for possible duplication of data.
Editorial Board
EDITORS
|
Robert D. Madoff, M.D.
Editor-in-Chief
Minneapolis, Minnesota
|
Julio García-Aguilar, M.D.
Coeditor
Duarte, California
|
Thomas E. Read, M.D.
Coeditor
Burlington, Massachusetts
|
SECTION EDITORS
|
W. Donald Buie, M.D.
Current Status
Self-Assessment
Calgary, Alberta, Canada
William C. Cirocco, M.D.
Selected Abstracts
Kansas City, Kansas |
Tracy Hull, M.D.
Dynamic Articles
Cleveland, Ohio
David A. Margolin, M.D.
Web Editor
New Orleans, Louisiana |
John R. T. Monson, M.D.
Media Reviews
For Debate
Rochester, New York
|
|
ASSOCIATE EDITORS
|
Wayne L. Ambroze, Jr., M.D.
Atlanta, Georgia
Nancy N. Baxter, M.D.
Toronto, Ontario, Canada
Roberto Bergamaschi, M.D.
Stony Brook, New York
Kelli Bullard Dunn, M.D.
Buffalo, New York
Bard Cosman, M.D.
San Diego, California
Conor Delaney, M.D., Ph.D.
Cleveland, Ohio
Emily Finlayson, M.D,, M.S,
Ann Arbor, Michigan
Susan Galandiuk, M.D.
Louisville, Kentucky
Samantha Hendren, M.D.
Ann Arbor, Michigan
Andreas Kaiser, M.D.
Los Angeles, California |
Henrik Kehlet, M.D.
Copenhagen, Denmark
Fumio Konishi, M.D.
Saitama, Japan
Najjia N. Mahmoud, M.D.
Philadelphia, Pennsylvania
Klaus E. Matzel, M.D.
Erlangen, Germany
Justin A. Maykel, M.D.
Worcester, Massachusetts
Bruce D. Minsky, M.D.
Chicago, Illinois
Arden Morris, M.D.
Ann Arbor, Michigan
Matthew Mutch, M.D.
St. Louis, Missouri
P. Ronan O'Connell, M.D.
Dublin, Ireland
Lisa Poritz, M.D.
Hershey, Pennsylvania
John C. Reilly, M.D.
Erie, Pennsylvania |
Rocco Ricciardi, M.D., M.P.H.
Burlington, Massachusetts
Anthony J. Senagore, M.D.
Grand Rapids, Michigan
Michael J. Solomon, M.Sc.
Sydney, Australia
Scott Steele, M.D.
Fort Lewis, Washington
Larissa Temple, M.D.
New York, New York
Emmanuel Tiret, M.D.
Paris, France
Madhulika Varma, M.D.
San Francisco, California
Masahiko Watanabe, M.D.
Kanagawa, Japan
Toshiaki Watanabe, M.D.
Tokyo, Japan
Bruce P. Waxman, M.B.B.S.
Melbourne, Australia |
EMERITI EDITORS-IN-CHIEF
Victor W. Fazio, M.B., M.S. Robert W. Beart, Jr., M.D. John R. Hill, M.D. Louis A. Buie, Sr.,M.D.
|
EDITORIAL OFFICE
|
5010 48th St. NE,
Rochester, Minnesota 55906
Fax: (507) 285-1986 |
Nancy Truax
Editorial Assistant
Phone: (507) 281-1302
ntruax@mayo.edu
|
Pat Oldenburg
Managing Editor
Phone: (507) 289-0485
oldenburg.patricia@mayo.edu |
|
